Core Viewpoint - The article highlights significant developments in various sectors, including finance, technology, and healthcare, indicating a dynamic market environment with potential investment opportunities. Macro News - The People's Bank of China announced that the Loan Prime Rate (LPR) for one year remains at 3.0% and for five years or more at 3.5%, unchanged from the previous month [5] - The People's Bank of China and the Hong Kong Monetary Authority launched a "Cross-Border Payment Link" to connect payment systems, officially going live on June 22 [5] - The State Administration for Market Regulation is conducting a national quality supervision inspection on 164 products, sampling over 16,000 batches [5] - The Ministry of Finance reported that from January to May 2025, national public budget revenue was 96,623 billion yuan, a year-on-year decrease of 0.3%, while expenditure was 112,953 billion yuan, a year-on-year increase of 4.2% [6] Market Highlights - The China Securities Regulatory Commission (CSRC) is seeking public opinion on the revised "Securities Company Classification Evaluation Regulations," aiming to enhance the evaluation framework and support high-quality development [12] - The first public REITs projects in China have raised over 180 billion yuan in total issuance since their launch, with a total market value exceeding 200 billion yuan [12] - The CSRC approved the registration of pure benzene futures and options, which will enhance risk management tools in the chemical industry [12] - Southbound capital has net bought over 650 billion yuan this year, with public funds accelerating their investment in Hong Kong stock thematic funds [14] Company Dynamics - Tesla signed a contract for its first grid-side energy storage project in mainland China, valued at 4 billion yuan [2] - 澜起科技 announced plans to issue H-shares and list on the Hong Kong Stock Exchange [3] - 华为 launched the developer beta for HarmonyOS 6 at its developer conference [19] - 九号公司 reported a 93% year-on-year increase in sales for its smart electric vehicles during the "618" shopping festival, totaling over 3.24 billion yuan [20] - 甘李药业's insulin product showed promising results in a clinical study presented at the American Diabetes Association conference [20] - 常山药业 received approval for clinical trials of a new weight loss drug [22] - 任子行 announced it would be subject to risk warnings due to an administrative penalty from the CSRC [22]
A股重要新规，今起施行；40亿元，特斯拉签了！900亿芯片龙头，宣布赴港IPO→
新华网财经·2025-06-23 00:31